H.Con.Res. 178

Recognizing the need to pursue research into the causes, a treatment, and an eventual cure for idiopathic pulmonary fibrosis, supporting the goals and ideals of National Idiopathic Pulmonary Fibrosis Awareness Week, and for other purposes.

Latest
        [Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[H. Con. Res. 178 Referred in Senate (RFS)]

109th CONGRESS
1st Session
H. CON. RES. 178

_______________________________________________________________________

IN THE SENATE OF THE UNITED STATES

September 30, 2005

Received and referred to the Committee on Health, Education, Labor, and
Pensions

_______________________________________________________________________

CONCURRENT RESOLUTION

Recognizing the need to pursue research into the causes, a treatment,
and an eventual cure for idiopathic pulmonary fibrosis, supporting the
goals and ideals of National Idiopathic Pulmonary Fibrosis Awareness
Week, and for other purposes.

Whereas idiopathic pulmonary fibrosis is a serious lung disorder causing
progressive, incurable lung scarring;
Whereas idiopathic pulmonary fibrosis is one of about 200 disorders called
interstitial lung diseases;
Whereas idiopathic pulmonary fibrosis is the most common form of interstitial
lung disease;
Whereas idiopathic pulmonary fibrosis is a debilitating and generally fatal
disease marked by progressive scarring of the lungs, causing an
irreversible loss of the lung tissue's ability to transport oxygen;
Whereas idiopathic pulmonary fibrosis progresses quickly, often causing
disability or death within a few short years;
Whereas there is no proven cause of idiopathic pulmonary fibrosis;
Whereas approximately 83,000 United States citizens have idiopathic pulmonary
fibrosis, and 31,000 new cases are diagnosed each year;
Whereas idiopathic pulmonary fibrosis is often misdiagnosed or underdiagnosed;
Whereas the median survival rate for idiopathic pulmonary fibrosis patients is 2
to 3 years, and about two thirds of idiopathic pulmonary fibrosis
patients die within 5 years; and
Whereas a need has been identified to increase awareness and detection of this
misdiagnosed and underdiagnosed disorder: Now, therefore, be it
Resolved by the House of Representatives (the Senate concurring),
That the Congress--
(1) recognizes the need to pursue research into the causes,
a treatment, and an eventual cure for idiopathic pulmonary
fibrosis;
(2) supports the work of advocates and organizations in
educating, supporting, and providing hope for individuals who
suffer from idiopathic pulmonary fibrosis, including efforts to
organize a National Idiopathic Pulmonary Fibrosis Awareness
Week;
(3) supports the designation of an appropriate week as
National Idiopathic Pulmonary Fibrosis Awareness Week;
(4) encourages the President to issue a proclamation
designating a National Idiopathic Pulmonary Fibrosis Awareness
Week;
(5) congratulates advocates and organizations for their
efforts to educate the public about idiopathic pulmonary
fibrosis, while funding research to help find a cure for this
disorder; and
(6) supports the goals and ideals of National Idiopathic
Pulmonary Fibrosis Awareness Week.

Passed the House of Representatives September 29, 2005.

Attest:

JEFF TRANDAHL,

Clerk.

By Gerasimos C. Vans,

Deputy Clerk.